The Effectiveness of Glycosaminoglycans in Peripheral Vascular Disease Therapy: A Clinical and Experimental Trial

Journal of International Medical Research

Volumn 13, Issue 1, 1985, Pages 40-47

  Corsi, C ^a   Bocci, L ^a   Cipriani, C ^a   Gazzini, A ^a   Marrapodi, E ^a  

^a NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSAMINOGLYCAN; PLACEBO; SULODEXIDE;

BLOOD AND HEMOPOIETIC SYSTEM; BLOOD CLOTTING; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG THERAPY; HUMAN; LIPID BLOOD LEVEL; LIPID METABOLISM; PERIPHERAL VASCULAR DISEASE; PERIPHERAL VASCULAR SYSTEM; PRIORITY JOURNAL; THERAPY;

AGED; ARTERIOSCLEROSIS; CHOLESTEROL, HDL; CLINICAL TRIALS; DOUBLE-BLIND METHOD; FEMALE; FEMORAL ARTERY; FIBRINOGEN; GLYCOSAMINOGLYCANS; HUMANS; INTERMITTENT CLAUDICATION; MALE; RANDOM ALLOCATION; TRIGLYCERIDES; VASCULAR DISEASES;

EID: 0021917821     PISSN: 03000605     EISSN: 14732300     Source Type: Journal    
DOI: 10.1177/030006058501300106     Document Type: Article

References (28)

1. Avogaro P (1977) Effects of the extractive heparinoid, glucuronylglucosaminoglycan sulfate (3GS), on human plasma lipids. Pharmacological Research Communications 9, 977.
2. Beaumont J L (1970) Classification of hyperlipidemias and hyperlipoproteinemias. Bulletin of the World Health Organization 43, 891.
3. Bianchini P (1972) Blood levels of the clearing factor after administration of a natural glucoronoglycosaminoglycan. Biochemistry and Experimental Biology 10, 243.
4. Brugni N Tarugi P Calandra S (1984) Effetto del Sulodexide sulla progressione dell'aterosclerosi sperimentale indotta nel coniglio da dieta aterogena. Ist. Patol. Generale dell'Univ. di Modena. Confidential Report, not published.
5. Corsi C Pollastri M (1978) Flussimetria a strain gauge. Generalità e modalità tecnica. Proceedings of the Congress “Semiologia strumentale incruenta delle arteropatie periferiche”. Chianciano Terme, 21/10/1978, p 85.
6. Day C E Powell J R Leys R S (1975) Sulphated polysaccharide inhibition of aortic uptake of low density lipoproteins. Artery 1, 126.
7. Di Perri T (1978) Action of intravenous glucosaminoglycan-sulphate on lipid blood components and blood viscosity in patients with acute regional vasculopathies. Giornale dell'Aterosclerosi 3, 41.
8. Fredrikson D S Lees R S (1965) A system for phoenotyping hyperlipoproteinemias. Circulation 31, 321.
9. Guyton J R (1980) Inhibition of rat arterial smooth muscle cell proliferation by heparin. In vivo studies with anticoagulant and non-anticoagulant heparin. Circulation Research 46, 625.
10. Hoffmann J (1978) Glukuronyl-glycosamin-glykansulfat (Sulodexide) in der behandlung der hyperlipämie. Therapie Woche 28, 9165.
11. Hoover R L (1980) Inhibition of rat arterial smooth muscle cell proliferation by heparin. Circulation Research 47, 4.
12. Lindahl U Hook M (1978) Glycosaminoglycans and their binding to biological macromolecules. Annual Review of Biochemistry 47, 385.
13. Mancini M (1980) Role of diet in atherosclerosis. Atherosclerosis Review 7, 157.
14. Nakashima Y (1975) The interaction of human plasma glycosaminoglycans with plasma lipoproteins. Journal of Biological Chemistry 250, 5386.
15. Oriente P (1980) Variazioni della composizione delle lipoproteine del siero e dell'attività lipoproteinlipasica indotte dal glucoronilglucosaminoglicano solfato (3GS): Confronto con l'eparina sodica. Giornale dell'Aterosclerosi 5, 159.
16. Palazzini E Procida C (1978) Effect of some mucopolysaccharides on activated factor X. Biochemical Pharmacology 27, 608.
17. Palazzini E Verardi S (1981) Effect of a naturally occurring mucopolysaccharide, 3-GS, on coagulative and lipemic parameters in patients under chronic hemodialitic treatment. Current Therapeutic Research 29, 678.
18. Palmieri G (1985) Sulodexide in the treatment of peripheral arterial disease. Clinical Trials Journal (in press).
19. Perego M Nazzari M Palmieri G (1981) 3-glucosamin-glicano-solfato per via parenterale in pazienti aterosclerotici iperlipidemici. Giornale dell‘-Arteriosclerosi 6, 289.
20. Pollastri M (1981) Valori e limiti della flussimetria nella diagnostica delle arteriopatie degli arti. Minerva Angiologica 6, 417.
21. Prino G Mantovani M (1969) In vitro effect of ateroid on the fibrinolytic activity in rat euglobulins. European Pharmacology 6, 190.
22. Radhakrishnamurthy B (1978) Studies of glycosaminoglycan composition and biological activity of Vessel, a hypolipidemic agent. Atherosclerosis 31, 217.
23. Ross R (1981) Atherosclerosis: A problem of the biology of arterial wall cells and their interaction with blood components. Ateriosclerosis 1, 293.
24. Rusconi C Orlando G (1975) Sull'azione antitrombogenetica di una nuova sostanza estrattiva: 3GS. Minerva Cardioangiologica 23, 1.
25. Saba P (1980) Clinical investigation on efficacy of extractive glucoronoglycosaminoglycan sulphate in cases of hyperlipidemia. Current Therapeutic Research 28, 535.
26. Sarno A (1980) Andamento dei fattori emoviscosimetrici, del fibrinogeno e di alcune glicoproteine in pazienti con vasculopatia sclerotica obliterante periferica trattati con 3GS. La Clinica Terapeutica 95, 289.
27. Singh J (1977) Plasma glycosaminoglycans in normal individuals of various age. Atherosclerosis 28, 319.
28. Sirtori C R (1976) In vivo and in vitro effect of sulphated mucopolisaccaride (3GS) on the aortic uptake of a cholesterol rich VLDL in rabbits. Artery 2, 390.